| Income Statement |
| Total Revenue | 500.00K |
|
| Revenues (USD) | 500.00K |
| Gross Profit | 500.00K |
| Operating Expenses | 12.20M |
| Research and Development Expense | 7.40M |
| Selling, General and Administrative Expense | 4.80M |
| Operating Income | -11.70M |
| Net Income | -10.57M |
| Net Income Common Stock | -10.57M |
| Net Income Common Stock (USD) | -10.57M |
| Consolidated Income | -10.57M |
| Earnings per Basic Share | -0.05 |
| Earnings per Basic Share (USD) | -0.05 |
| Earnings per Diluted Share | -0.05 |
| Earning Before Interest & Taxes (EBIT) | -10.57M |
| Earning Before Interest & Taxes (USD) | -10.57M |
| Weighted Average Shares | 211.38M |
| Weighted Average Shares Diluted | 211.38M |
| Balance Sheet |
| Cash and Equivalents | 125.23M |
| Cash and Equivalents (USD) | 125.23M |
| Trade and Non-Trade Receivables | 500.00K |
| Current Assets | 127.26M |
| Total Assets | 127.32M |
| Current Liabilities | 5.25M |
| Total Liabilities | 5.57M |
| Accumulated Retained Earnings (Deficit) | -172.90M |
| Shareholders Equity | 121.75M |
| Shareholders Equity (USD) | 121.75M |
| Assets Non-Current | 55.00K |
| Liabilities Non-Current | 321.00K |
| Trade and Non-Trade Payables | 1.84M |
| Cash Flow |
| Net Cash Flow from Financing | 147.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.46M |
| Issuance (Purchase) of Equity Shares | 147.00K |
| Net Cash Flow from Operations | -7.60M |
| Share Based Compensation | 4.79M |